LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL

Clinical trials for LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL trials appear

Sign up with your email to follow new studies for LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Three-Pronged attack tested against Tough-to-Treat blood cancer

Disease control Completed

This study tested a combination of three medicines—ibrutinib, fludarabine, and pembrolizumab—for adults with a hard-to-treat form of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if using these drugs together could achieve a complete …

Matched conditions: LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL

Get alerted when new LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL trials appear

Three-Pronged attack tested against Tough-to-Treat blood cancer